Agreement - November 16, 2015
Enzymatica signs distribution agreement
Enzymatica has partnered with Esteve, a leading pharmaceutical company in Spain. The agreement provides Esteve with exclusive rights to sell, market and distribute ColdZyme to pharmacies in Spain and Andorra. The agreement covers Enzymatica’s products ColdZyme 20 ml and ColdZyme One Cold, 7 ml. In Spain the products will be sold under the co-brand Cortagrip/ColdZyme. “The […]
Agreement - November 9, 2015
Targovax in new agreements
Ludwig Cancer Research and the Cancer Research Institute (CRI) has made an agreement with Oslo Cancer Cluster member Targovax to evaluate its experimental virotherapy, ONCOS-102, in early phase clinical trials testing the virotherapy in combination with other, potentially synergistic immunotherapies such as checkpoint inhibitors. “We believe oncolytic virotherapy-in which engineered viruses are deployed against cancer cells-holds […]
Agreement - November 5, 2015
Moberg Pharma, Colep enter agreement
Moberg Pharma and Colep have entered a development agreement for MOB-015, a novel topical formulation of terbinafine for onychomycosis (nail fungus). Under the agreement, Colep’s Healthcare Division will share funding by conducting a pharmaceutical development program which will include scale-up of manufacturing processes, stability programs and supply of clinical trial material for the Phase 3 […]
Agreement - October 26, 2015
Vigmed signs distribution agreement for Finland
The company has signed an exclusive distribution agreement for Finland. This means that it has full coverage in all Nordic countries. To add to the growing list of markets where exclusive distribution agreements are in place, Vigmed now adds Finland to their network of distributors for their patented safety products. OY Vestek AB will be […]
Agreement - October 20, 2015
DexTech in research agreement
Roche and DexTech have signed a research agreement with the aim to share DexTech’s know-how and proprietary glycosylation technology for applications in one of Roche’s oncology projects based on monoclonal antibodies. DexTech owns two globally granted patents relating to electrostatically modified dextrans for applications in cancer treatment. Roche will fund the research with EUR 50,000 […]
Agreement - October 16, 2015
C-RAD signs agreement with GE
GE Healthcare has entered into a sales and distribution agreement for C-RAD’s Sentinel 4DCT™ systems and Cyrpa High Impact Technology (HIT) laser systems. C-RAD’s systems are used for 4D imaging and virtual simulation in radiation therapy. GE will offer these solutions through its price book, making them available to the GE salesforce and their customers […]
